Categories for Presentation (sv)

Positiv status efter Q2-rapporten

August 8, 2023 8:32 am Published by jonas Leave your thoughts

Sitdown 22 februari 2023

February 22, 2023 3:20 pm Published by jonas Leave your thoughts

Stora Aktiedagen Göteborg 8 november 2022

November 14, 2022 8:00 am Published by jonas Leave your thoughts

Finwire videointervju

November 1, 2022 8:30 am Published by jonas Leave your thoughts

Redwood Pharma hos Aktieportföljen Live

October 14, 2022 11:23 am Published by jonas Leave your thoughts

Redwood Pharma – Aktiedagen Lund 26 september 2022

September 27, 2022 10:18 am Published by jonas Leave your thoughts

BioStock Investor Meeting September 2022 | Redwood Pharma

September 21, 2022 5:33 pm Published by jonas Leave your thoughts

BioStock Life Science Spring Summit 2022

June 13, 2022 1:10 pm Published by jonas Leave your thoughts

Redwood Pharma – Interview with CEO

November 30, 2021 2:28 pm Published by jonas Leave your thoughts

Aktiedagen Lund 27 januari 2021

February 3, 2021 9:15 am Published by jonas Leave your thoughts

Redwood Pharma

We develop ophthalmic drugs that address major medical needs. We focus on early-stage clinical development. Our long-term strategy is to enter into licence agreements with other drug companies who will in turn introduce products for the global market.

Redwood Pharma

Vi utvecklar ögonläkemedel för stora medicinska behov. Tonvikten ligger på tidig klinisk utveckling. Den långsiktiga strategin är att teckna licensavtal med andra läkemedelsbolag, som i sin tur kan introducera produkterna på världsmarknaden.